Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nephroceuticals is a specialized healthcare company focused on the development and distribution of nutritional supplements tailored for patients with kidney disease. The company's primary product line, ProRenal+D, provides a combination of renal-specific multivitamins and Vitamin D, with some formulations including Omega-3 fatty acids to support cardiovascular health in renal patients. These products are designed based on clinical guidelines to address the unique nutritional deficiencies common in individuals with chronic kidney disease and those undergoing dialysis. Nephroceuticals operates primarily in the United States, marketing its products directly to patients and through recommendations from nephrology professionals. The company emphasizes evidence-based formulations that comply with the National Kidney Foundation's nutritional recommendations. By focusing exclusively on the renal community, Nephroceuticals aims to improve the long-term health outcomes and quality of life for patients managing complex kidney conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nephroceuticals.